BFA
IMMU

BlackRock Fund Advisors’s Immunomedics Inc IMMU Stock Holding History

BlackRock Fund Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$16.9M Buy
4,604,697
+861,635
+23% +$2.55M ﹤0.01% 2277
2016
Q3 		$12.2M Buy
3,743,062
+241,586
+7% +$676K ﹤0.01% 2351
2016
Q2 		$8.12M Sell
3,501,476
-248,272
-7% -$830K ﹤0.01% 2520
2016
Q1 		$9.37M Buy
3,749,748
+59,765
+2% +$134K ﹤0.01% 2389
2015
Q4 		$11.3M Sell
3,689,983
-216,524
-6% -$604K ﹤0.01% 2372
2015
Q3 		$6.72M Buy
3,906,507
+157,491
+4% +$402K ﹤0.01% 2612
2015
Q2 		$15.2M Buy
3,749,016
+218,347
+6% +$893K ﹤0.01% 2280
2015
Q1 		$13.5M Buy
3,530,669
+100,658
+3% +$438K ﹤0.01% 2279
2014
Q4 		$16.5M Buy
3,430,011
+304,348
+10% +$1.2M ﹤0.01% 2174
2014
Q3 		$11.6M Sell
3,125,663
-13,875
-0.4% -$46.9K ﹤0.01% 2260
2014
Q2 		$11.5M Buy
3,139,538
+46,955
+2% +$172K ﹤0.01% 2337
2014
Q1 		$13M Buy
3,092,583
+136,570
+5% +$677K ﹤0.01% 2238
2013
Q4 		$13.6M Sell
2,956,013
-19,570
-0.7% -$87.1K ﹤0.01% 2201
2013
Q3 		$18.4M Buy
2,975,583
+380,495
+15% +$2.19M 0.01% 2015
2013
Q2 		$14.1M Buy
+2,595,088
New +$8.52M 0.01% 2052

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

BlackRock Fund Advisors's IMMU Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Immunomedics Inc (IMMU) stake by 23% in Q4 2016, buying an estimated $2.55M and bringing the position to 4,604,697 shares worth $16.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2277.

BlackRock Fund Advisors first reported a position in IMMU in Q2 2013 and has held it in 15 quarters since. The position peaked at $18.4M in Q3 2013. 109 funds tracked by Wall St. Rank hold IMMU as of Q4 2016.

  • BlackRock Fund Advisors held 4,604,697 shares of Immunomedics Inc worth $16.9M as of Q4 2016.
  • BlackRock Fund Advisors bought 861,635 Immunomedics Inc shares in Q4 2016, an estimated $2.55M.
  • Immunomedics Inc made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2277 holding.
  • BlackRock Fund Advisors first reported a position in Immunomedics Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Immunomedics Inc position peaked at $18.4M in Q3 2013.
  • 109 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.